Experimental acute cerebral ischemia with reperfusion: Evaluation with gadolinium-texaphyrin

Investigative Radiology

Volumn 31, Issue 6, 1996, Pages 353-358

  Young, Stuart W ^a   Fan, Qing ^a   Kunis, David M ^b   Steinberg, Gary K ^b  

^a PHARMACYCLICS INC   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

brain, ischemia; expanded porphyrin; Gadolinium; magnetic resonance, contrast media; texaphyrin complex

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM TEXAPHYRIN; PCI 0101; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PERFUSION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RABBIT; REPERFUSION; SIGNAL DETECTION;

EID: 0029946214     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-199606000-00007     Document Type: Article

References (13)

1. Heros RC. Stroke: Early pathophysiology and treatment. Summary of the Fifth Annual Decade of the Brain Symposium. Stroke 1994;25:1877-1881.
2. Yuh WTC, Crain MR, Loes DL, Greene GM, Ryals TJ, Sato Y. MR imaging of cerebral ischemia: Findings in the first 24 hours. AJR Am J Roentgenol 1991;157:565-573.
3. Steinberg GK, Kunis D, Saleh J, DeLaPaz R. Neuroprotection by N-methyl-D-aspartate antagonist dextrorphan is dependent upon plasma and brain levels. J Cereb Blood Flow Metab 1991;11:1015-1023.
4. Lo EH, Steinberg GK. Effects of hypothermia on evoked potentials, magnetic resonance imaging, and blood flow in focal ischemia in rabbits. Stroke 1992;23:889-893.
5. Bryan RN, Whitlow WD, Levy LM. Cerebral infarction and ischemic disease. In: Atlas SW, ed. Magnetic resonance imaging of the brain and spine. New York, NY: Raven Press, 1991.
6. Crain MR, Yuh WTC, Greene GM, et al. Cerebral ischemia: Evaluation with contrast-enhanced MR imaging. AJR Am J Roentgenol 1991;157:575-583.
7. Mathews VP, Monsein LH, Pardo CA, Bryan RN. Histologic abnormalities associated with gadolinium enhancement on MR in the initial hours of experimental cerebral infarction. AJNR Am J Neuroradiol 1994;15:573-579.
8. Mathews VP, King JC, Elster AD, Hamilton CA. Cerebral infarction: Effects of dose and magnetization transfer saturation at gadolinium-enhanced MR imaging. Radiology 1994;190:547-552.
9. Runge VM, Kirsch JE, Wells JW, Dunworth JN, Woolfolk CE. Visualization of blood-brain barrier disruption on MR images of cats with acute cerebral infarction: Value of administering a high dose of contrast material. AJR Am J Roentgenol 1994;162: 431-435.
10. Nagahiro S, Goto S, Korematsu K, Sumi M, Takahashi M, Ushio Y. Disruption of the blood-cerebrospinal fluid barrier by transient cerebral ischemia. Brain Res 1994;633:305-11.
11. Young SW, Sidhu MK, Qing F, et al. Preclinical evaluation of gadolinium (III) texaphyrin complex: A new paramagnetic contrast agent for magnetic resonance imaging. Invest Radiol 1994;29: 330-338.
12. DeLaPaz RL, Shibata D, Steinberg GK, Zarnegar R, George C. Acute cerebral ischemia in rabbits: Correlation between MR and histopathology. AJNR Am J Neuroradiol 1991;12:89-95.
13. Virapongese C, Mancuso A, Quisling R. Human brain infarcts: Gd-DTPA-enhanced MR imaging. Radiology 1986;161:785-794.